VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) [NBP2-29335] - VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) Chemical structure of the ROR gamma T ...read more
VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) [NBP2-29335] - VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor)VPR-66 inhibition of transcriptional ...read more
VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) [NBP2-29335] - VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) VPR-66 inhibition of transcriptional ...read more
VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor) Summary
Immunogen
VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor)
Applications/Dilutions
Application Notes
The ROR gamma T inhibitor is readily soluble in DMSO. This inhibitor should be dissolved in DMSO, ethanol, or other similar organic solvents. The solubility in DMSO exceeds 10 mg/ml. The aqueous solubility is greater than 0.5 mg/ml. Previous studies have used 10 mM stock solutions in DMSO. Prepare concentrated intermediate dilutions in DMSO and then add small volumes to buffer or cell culture media to provide the final aqueous working concentrations. It is not recommended to prepare serial dilutions in aqueous media.
Publications
Read Publications using NBP2-29335 in the following applications:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Buffer
Crystalline, off-white solid; MW = 287.4
Concentration
LYOPH
Reconstitution Instructions
Please contact technical support for detailed reconstitution instructions.
Alternate Names for VPR-66, ROR gamma T and ROR alpha Inhibitor (ROR gamma T and ROR alpha Inhibitor)
VPR 66
VPR66
Background
h17 cells are a sub-type of T-helper cells that secrete IL-17 and other pro-inflammatory cytokines. Th17 cells have been implicated in driving the pathophysiology of several human autoimmune diseases. Retinoic Acid-Related Orphan Nuclear, Receptors (ROR) are canonical nuclear receptors with transcriptional activity at specific DNA response elements. Although most nuclear receptors are regulated by ligand binding no cognate ligands(s) have been definitively identified for any ROR protein. There are three different ROR proteins: RORa, RORb and RORg. An isoform of RORg, called ROR gamma T, is exclusively expressed in lymphocytes. Together, RORa and ROR gamma T are critical transcription factors required for differentiation of naive CD4+ Tcells into Th17 cells.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Inhibitors are guaranteed for 1 year from date of receipt.
Publications for VPR-66, ROR gamma T and ROR alpha Inhibitor Inhibitor (NBP2-29335)(2)
We have publications tested in 1 confirmed species: Human.
Reviews for VPR-66, ROR gamma T and ROR alpha Inhibitor Inhibitor (NBP2-29335) (0)
There are no reviews for VPR-66, ROR gamma T and ROR alpha Inhibitor Inhibitor (NBP2-29335).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for VPR-66, ROR gamma T and ROR alpha Inhibitor Inhibitor (NBP2-29335). (Showing 1 - 1 of 1 FAQs).
Do you have data for concentration for mouse injection (in-vivo)?
We don't have any data on in vivo use of the inhibitor, nor know of any publications. However, we would recommend a starting dose of 20 mg/kg and going up in dosage from there. You would need to empirically determine the suitability of the inhibitor for your mouse model system as well as optimize the dosage. The compound can be stored long term at -80.
Additional VPR-66, ROR gamma T and ROR alpha Inhibitor Products